219 related articles for article (PubMed ID: 10707937)
41. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.
Pakala SV; Chivetta M; Kelly CB; Katz JD
J Exp Med; 1999 Apr; 189(7):1053-62. PubMed ID: 10190896
[TBL] [Abstract][Full Text] [Related]
42. Administration of monoclonal antibodies against vascular cell adhesion molecule-1/very late antigen-4 abrogates predisposing autoimmune diabetes in NOD mice.
Tsukamoto K; Yokono K; Amano K; Nagata M; Yagi N; Tominaga Y; Moriyama H; Miki M; Okamoto N; Yoneda R
Cell Immunol; 1995 Oct; 165(2):193-201. PubMed ID: 7553883
[TBL] [Abstract][Full Text] [Related]
43. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
44. Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism.
Meagher C; Beilke J; Arreaza G; Mi QS; Chen W; Salojin K; Horst N; Cruikshank WW; Delovitch TL
Diabetes; 2010 Nov; 59(11):2862-71. PubMed ID: 20693344
[TBL] [Abstract][Full Text] [Related]
45. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
46. Immunomodulation through inhibition of multiple adhesion molecules generates resistance to autoimmune diabetes in NOD mice.
Ninova D; Dean PG; Stegall MD
J Autoimmun; 2004 Nov; 23(3):201-9. PubMed ID: 15501391
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-26a Promotes Regulatory T cells and Suppresses Autoimmune Diabetes in Mice.
Ma H; Zhang S; Shi D; Mao Y; Cui J
Inflammation; 2016 Feb; 39(1):1-9. PubMed ID: 26208605
[TBL] [Abstract][Full Text] [Related]
48. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
[TBL] [Abstract][Full Text] [Related]
49. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
50. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
[TBL] [Abstract][Full Text] [Related]
51. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice.
Reddy S; Liu W; Elliott RB
Immunol Cell Biol; 1994 Oct; 72(5):390-7. PubMed ID: 7835983
[TBL] [Abstract][Full Text] [Related]
52. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
[TBL] [Abstract][Full Text] [Related]
53. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
[TBL] [Abstract][Full Text] [Related]
54. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice.
DiCosmo BF; Picarella D; Flavell RA
Int Immunol; 1994 Dec; 6(12):1829-37. PubMed ID: 7696203
[TBL] [Abstract][Full Text] [Related]
55. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
[TBL] [Abstract][Full Text] [Related]
56. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.
Wong FS; Visintin I; Wen L; Flavell RA; Janeway CA
J Exp Med; 1996 Jan; 183(1):67-76. PubMed ID: 8551245
[TBL] [Abstract][Full Text] [Related]
57. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.
Calderon B; Suri A; Pan XO; Mills JC; Unanue ER
J Immunol; 2008 Nov; 181(10):6964-74. PubMed ID: 18981116
[TBL] [Abstract][Full Text] [Related]
58. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
Aboumrad E; Madec AM; Thivolet C
Clin Exp Immunol; 2007 Jun; 148(3):432-9. PubMed ID: 17374136
[TBL] [Abstract][Full Text] [Related]
59. Pathogenic and protective roles of CD45RB(low) CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse.
Shimada A; Rohane P; Fathman CG; Charlton B
Diabetes; 1996 Jan; 45(1):71-8. PubMed ID: 8522063
[TBL] [Abstract][Full Text] [Related]
60. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice.
Hill NJ; Van Gunst K; Sarvetnick N
J Immunol; 2003 Feb; 170(4):1649-58. PubMed ID: 12574327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
